|
Prostate Cancer and supplementation
with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial
ABSTRACT:
BACKGROUND: Epidemiologic studies have
suggested that
vitamin E and beta-carotene may each influence the
development of prostate cancer. In the
Alpha-Tocopherol,
Beta-Carotene Cancer Prevention Study, a controlled trial, we studied the
effect of
alpha-tocopherol (a form of vitamin E) and
beta-carotene
supplementation, separately or together, on prostate cancer in male smokers.
METHODS:
A total of 29,133 male smokers aged 50-69 years from southwestern Finland were randomly
assigned to receive
alpha-tocopherol (50mg),
beta-carotene
(20mg), both agents, or placebo daily for 5-8 years (median, 6.1 years). The
supplementation effects were estimated by a proportional hazards model, and two- sided P
values were calculated.
RESULTS:
We found 246 new cases of and 62 deaths from prostate cancer during the follow-up period.
A 32% decrease (95% confidence interval (CI)= -47% to 12%) in the incidence of prostate
cancer was observed among the subjects receiving
alpha-tocopherol
(n=14564) compared with those not receiving
alpha-tocopherol
(n=14569). The reduction was evident in clinical prostate cancer but not in latent cancer.
Mortality from prostate cancer was 41% lower (95% CI=-65% to 1%) among men receiving
alpha-tocopherol.
Among subjects receiving
beta-carotene (n=14560), prostate cancer incidence was 23%
higher (95% CI=30%-89%) compared with those not receiving
beta-carotene.
(n=14573). Neither agent had any effect on the time interval between diagnosis and death.
CONCLUSIONS: Long-term supplementation with
alpha-tocopherol
substantially reduced prostate cancer incidence and mortality in male smokers. Other
controlled trials are required to confirm the findings.
Heinonen OP; Albanes D; Virtamo J; Taylor PR; Huttunen JK; Hartman AM; Haapakoski J;
Malila N; Rautalahti M; Ripatti S; Maenpaa H; Teerenhovi L; Koss L; Virolainen M
Edwards BK. Department of Public Health, University of Helsinki, Finland. J Natl Cancer
Inst 1998 Mar 18;90(6):440-6. NLM CIT.ID:98180463. COMMENT: J Natl Cancer Inst 1998 Mar
18;90(6):414-5. J Natl Cancer Inst 1998 Mar 18;90(6):416-7.
Index
of Articles
Site Navigation and Quick Links
Home Health
Club Site Index
Library
Physicians Only
Checkout
Vitamins
Herbs
Minerals
Amino Acids Enzymes
Hormones
Homeopathics
Ayurveda
Glandulars
Fatty Acids
Xtra-Cell
Alphabetical Product Index
Health Function Index
Condition Specific Formulas
The
Latest Health Research
Prescription Drug Support Formulas
Frozen Cellular
Extracts Xtra-Cell
Top Products
New
Products
Optimum Health
Essentials
Ultra Preventive X
Contact Us
Customer Service
Privacy Policy
Conditions Of Use
Pricing, Availability and Returns
Privacy Companies
Development Team
Doctor Morrow
About Dr Morrow
Healing from
Within
The Power of Prayer
Prayer Requests
Featured Products
Featured Product
Top Products
New
Products
Optimum Health
Essentials
Ultra Preventive X
Ultra Preventive IX
Traumeel
Wobenzym N
Manufacturers
BHI
Douglas Laboratories
Heel
Metagenics
Nutrition Dynamics
Professional Health Products
Pure Encapsulations
Wobenzym
Checkout
Checkout
Physicians Checkout
Members
Member Zone
Physicians/Professionals/Affiliates
Signup Lost Password
Edit Profile
Nutrition Dynamics, Inc. 510 West Court Street Seguin, Texas 78155
Copyright © 1998-2008 All Rights Reserved Patent Pending
800.926.2906
|